Synthetic studies on gambieric acids, potent antifungal polycyclic ether natural products: Reassignment of the absolute configuration of the nonacyclic polyether core by NMR analysis of model compounds

Journal of Organic Chemistry

Volumn 74, Issue 11, 2009, Pages 4024-4040

  Fuwa, Haruhiko ^a   Ishigai, Kazuya ^a   Goto, Tomomi ^a   Suzuki, Akihiro ^a   Sasaki, Makoto ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABSOLUTE CONFIGURATION; ANTI-FUNGAL; CHEMICAL EQUATIONS; CONVERGENT SYNTHESIS; DIASTEREOSELECTIVE; MODEL COMPOUND; NATURAL PRODUCTS; NMR ANALYSIS; NMR CHEMICAL SHIFTS; NMR DATA; POLYCYCLIC ETHERS; RING FRAGMENTS; RING MODEL; SUZUKI-MIYAURA COUPLING; SYNTHETIC STUDY; TETRA-HYDROFURAN; VINYL IODIDES;

ACIDS; ETHERS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONTOLOGY; ORGANIC COMPOUNDS; SYNTHESIS (CHEMICAL);

COMPLEXATION;

ANTIFUNGAL AGENT; BORIC ACID; GAMBIERIC ACID A; GAMBIERIC ACID B; GAMBIERIC ACID DERIVATIVE; IODIDE; POLYETHER DERIVATIVE; TETRAHYDROFURAN; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIASTEREOISOMER; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ETHERIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SUZUKI REACTION;

ANTIFUNGAL AGENTS; BIOLOGICAL PRODUCTS; CIGUATOXINS; ETHERS, CYCLIC; FURANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 66249130049     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo900332q     Document Type: Article

References (51)

1. For reviews of marine polycyclic ether natural products, see: (a) Yasumoto, T.; Murata, M. Chem. Rev. 1993, 93, 1897-1909.
2. (b) Scheuer, P. J. Tetrahedron 1994, 50, 3-18.
3. (c) Murata, M.; Yasumoto, T. Nat. Prod. Rep. 2000, 293-314.
4. (d) Yasumoto, T. Chem. Rec. 2001, 1, 228-242.
5. For recent reviews of the synthesis of polycyclic ethers, see: (a) Marmsäter, F. P.; West, F. G. Chem. - Eur. J. 2002, 8, 4346-4353.
6. (b) Evans, P. A.; Delouvrie, B. Curr. Opin. Drug Discov. Dev. 2002, 5, 986-999.
7. (c) Inoue, M. Chem. Rev. 2005, 105, 4379-4405.
8. (d) Nakata, T. Chem. Rev. 2005, 105, 4314-4347.
9. (e) Fuwa, H.; Sasaki, M. Curr. Opin. Drug Discov. Dev. 2007, 10, 784-806.
10. (f) Sasaki, M.; Fuwa, H. Nat. Prod. Rep. 2008, 25, 401-426.
11. (g) Nicolaou, K. C.; Frederick, M. O.; Aversa, R. J. Angew. Chem., Int. Ed. 2008, 47, 7182-7225.
12. (a) Nagai, H.; Torigoe, K.; Satake, M.; Murata, M.; Yasumoto, T.; Hirota, H. J. Am. Chem. Soc. 1992, 114, 1102-1103.
13. (b) Nagai, H.; Murata, M.; Torigoe, K.; Satake, M.; Yasumoto, T. J. Org. Chem. 1992, 57, 5448-5453.
14. Morohashi, A.; Satake, M.; Nagai, H.; Oshima, Y.; Yasumoto, T. Tetrahedron 2000, 56, 8995-9001.
15. Nagai, H.; Mikami, Y.; Yazawa, K.; Gonoi, T.; Yasumoto, T. J. Antibiot. 1993, 46, 520-522.
16. Sakamoto, B.; Nagai, H.; Hokama, Y. Phycologia 1996, 35, 350-353.
17. Inoue, M.; Hirama, M.; Satake, M.; Sugiyama, K.; Yasumoto, T. Toxicon 2003, 41, 469-474.
18. (a) Kadota, I.; Oguro, N.; Yamamoto, Y. Tetrahedron Lett. 2001, 42, 3645-3647.
19. (b) Kadota, I.; Takamura, H.; Yamamoto, Y. Tetrahedron Lett. 2001, 42, 3649-3651.
20. (a) Clark, J. S.; Fessard, T. C.; Wilson, C. Org. Lett. 2004, 6, 1773-1776.
21. (b) Clark, J. S.; Kimber, M. C.; Robertson, J.; McErlean, C. S. P.; Wilson, C. Angew. Chem., Int. Ed. 2005, 44, 6157-6162.
22. Roberts, S. W.; Rainier, J. D. Org. Lett. 2007, 9, 2227-2230.
23. Saito, T.; Nakata, T. Org. Lett. 2009, 11, 113-116.
24. (a) Sato, K.; Sasaki, M. Org. Lett. 2005, 7, 2441-2444.
25. (b) Sato, K.; Sasaki, M. Angew. Chem., Int. Ed. 2007, 46, 2518-2522.
26. (c) Sato, K.; Sasaki, M. Tetrahedron 2007, 63, 5977-6003.
27. For preliminary communications of this work, see: (a) Fuwa, H.; Suzuki, A.; Sato, K.; Sasaki, M. Heterocycles 2007, 72, 139-144.
28. (b) Fuwa, H.; Goto, T.; Sasaki, M. Org. Lett. 2008, 10, 2211-2214.
29. Araki, K.; Saito, K.; Arimoto, H.; Uemura, D. Angew. Chem., Int. Ed. 2003, 43, 81-84.
30. Evans, D. A.; Bartroli, J.; Shih, T. L. J. Am. Chem. Soc. 1981, 103, 2127-2129.
31. Prashad, M.; Har, D.; Kim, H.-Y.; Repic, O. Tetrahedron Lett. 1998, 39, 7067-7070.
32. Fuwa, H.; Kainuma, N.; Tachibana, K.; Sasaki, M. J. Am. Chem. Soc. 2002, 124, 14983-14992.
33. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092-4096.
34. The numbering of carbon atoms of all compounds in this paper corresponds to that of the natural product.
35. For a review, see: Mitsunobu, O. Synthesis 1981, 1-28.
36. For selected related examples: (a) Fukuyama, T.; Wang, C.-L. J.; Kishi, Y. J. Am. Chem. Soc. 1979, 101, 260-262.
37. (b) Braddock, D. C.; Bhuva, R.; Millan, D. S.; Pérez-Fuertes, Y.; Roberts, C. A.; Sheppard, R. N.; Solanki, S.; Stokes, E. S. E.; White, A. J. P. Org. Lett. 2007, 9, 445-448.
38. (a) Barrett, A. G. M.; Peña, M.; Willardsen, J. A. J. Org. Chem. 1996, 61, 1082-1100.
39. (b) Scheidt, K. A.; Chen, H.; Follows, B. C.; Chemler, S. R.; Coffey, D. S.; Roush, W. R. J. Org. Chem. 1998, 63, 6436-6437.
40. For reviews of Suzuki-Miyaura coupling: (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457-2483.
41. (b) Chemler, S. R.; Trauner, D.; Danishefsky, S. J. Angew. Chem., Int. Ed. 2001, 40, 4544-4568.
42. Hori, N.; Matsukura, H.; Matsuo, G.; Nakata, T. Tetrahedron 2002, 58, 1853-1864.
43. Takano, S.; Samizu, K.; Sugihara, T.; Ogasawara, K. J. Chem. Soc., Chem. Commun. 1989, 1344-1345.
44. Myers, A. G.; Zheng, B.; Movassaghi, M. J. Org. Chem. 1997, 62, 7507.
45. Marshall, J. A.; Johns, B. A. J. Org. Chem. 1998, 63, 7885-7892.
46. It is interesting that the difference of the C12 position between hydroxy alkenes 2 and 19 affected the apparent diastereoselectivity of their respective bromoetherifications. However, we notice that the net yield of tricyclic compound 15 was 70% from hydroxy alkene 2, which is comparable to that of tricyclic compound 37 (69% yield from hydroxy alkene 19). Although the reason for this result is not clear, we speculate that the undesired mode of cyclization (i.e., Figure 2, TS-B) of 19 would result in decomposition of the substrate. Similarly, bromoetherification/reduction of hydroxy alkene 48 proceeded with a seemingly better diastereoselectivity (dr = 3.5:1) than that of hydroxy alkene 63 (dr = 2:1), but the net yield of the desired tricyclic compound 49 (47%) was almost the same as that of 65 (49%) (vide infra).
47. 5N. See the Supporting Information for details.
48. Nicolaou, K. C.; Nugiel, D. A.; Couladouros, E.; Hwang, C.-K. Tetrahedron 1990, 46, 4517-4552.
49. (a) Brunel, Y.; Rousseau, G. J. Org. Chem. 1996, 61, 5793-5800.
50. (b) Gao, X.; Snider, B. B. J. Org. Chem. 2004, 69, 5517-5527.
51. For a review, see: Nicolaou, K. C.; Snyder, S. A. Angew. Chem., Int. Ed. 2005, 44, 1012-1044.